Ilango Balakrishnan
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Mesenchymal stem cell research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Protein Degradation and Inhibitors 5
- Chromatin Remodeling and Cancer 5
- RNA Interference and Gene Delivery 2
- Oncology 6
- CAR-T cell therapy research 3
- Co-authors
- Nicholas K. Foreman (18 shared papers)Sujatha Venkataraman (22 shared papers)Rajeev Vibhakar (22 shared papers)Beverly Torok‐Storb (3 shared papers)Irina Alimova (11 shared papers)Manoj M. Pillai (3 shared papers)Diane K. Birks (7 shared papers)Peter S. Harris (6 shared papers)
- Journals
- Neuro-Oncology (7 papers)Oncotarget (3 papers)Blood (2 papers)Molecular Cancer Research (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Ilango Balakrishnan
26 papers receiving 573 citations
Peers
Comparison fields: 5 of 61
- Genetics 163
- Cancer Research 173
- Molecular Biology 388
- Hematology 43
- Oncology 90
Countries citing papers authored by Ilango Balakrishnan
This map shows the geographic impact of Ilango Balakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilango Balakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilango Balakrishnan more than expected).
Fields of papers citing papers by Ilango Balakrishnan
This network shows the impact of papers produced by Ilango Balakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilango Balakrishnan. The network helps show where Ilango Balakrishnan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ilango Balakrishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 94 | |
| 2 | 2014 | 89 | |
| 3 | 2013 | 66 | |
| 4 | 2014 | 57 | |
| 5 | 2010 | 51 | |
| 6 | 2012 | 40 | |
| 7 | 2016 | 33 | |
| 8 | 2020 | 29 | |
| 9 | 2021 | 27 | |
| 10 | 2017 | 21 | |
| 11 | 2016 | 16 | |
| 12 | 2017 | 14 | |
| 13 | 2020 | 10 | |
| 14 | 1987 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2024 | 5 | |
| 17 | 2016 | 3 | |
| 18 | 2002 | 2 | |
| 19 | 1990 | 2 | |
| 20 | 2011 | 1 |
About Ilango Balakrishnan
Ilango Balakrishnan is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Pathology and Forensic Medicine, having authored 30 papers that have together received 580 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (5 papers), Chromatin Remodeling and Cancer (5 papers), CAR-T cell therapy research (3 papers), MicroRNA in disease regulation (3 papers), Glioma Diagnosis and Treatment (3 papers), Advanced Radiotherapy Techniques (2 papers), Microtubule and mitosis dynamics (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Genetics (163 citations), Cancer Research (173 citations), Molecular Biology (388 citations), Hematology (43 citations) and Oncology (90 citations). Ilango Balakrishnan has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Nicholas K. Foreman, Sujatha Venkataraman, Rajeev Vibhakar, Beverly Torok‐Storb, Irina Alimova, Manoj M. Pillai, Diane K. Birks, Peter S. Harris, Michael D. Taylor and Michael H. Handler. Their work appears in journals such as Neuro-Oncology, Oncotarget, Blood, Molecular Cancer Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.